MaaT Pharma SA is involved in developing microbiome-based therapeutics. The company focuses on harnessing the gut microbiome to improve patient outcomes, particularly in cancer treatments and other health-related areas.
1923
France
51 - 200 employees
Biotechnology
$1M - 10M in revenue
N/A in profitability
CO2e per visit (g)
Industry benchmark
Total Annual
Revenue & EBITDA
($ B)
Margin as % of revenue
R&D as % of revenue
Analyst consensus vs actuals
($ B)
0.0
▼ 33.8%
0.0
▼ 19.4%
0.0
▼ 63.4%
0.0
2029| Target | Year | Value | Scope | Baseline |
|---|
Not available
Not available
Not available
Not available
4 out of 15 incl. management
Not available
Not available
Not available
Not available
Not available
Not available
Not available